Letter to the editor: Colchicine and risk of non-cardiovascular death in patients with coronary artery disease: a pooled analysis underlying possible safety concerns

The conclusion by Galli et al.1 that the use of colchicine in patients with coronary disease is associated with a significant increase in non-cardiovascular death is based on incorrect data. Their meta-analysis of four trials included Low-dose Colchicine (LoDoCo), a randomized trial comparing colchicine with control in 532 patients with stable coronary artery disease.2 Unfortunately, Galli et al. did not include non-cardiovascular deaths that...